WAF1 accumulation by carbon-ion beam and α-particle irradiation in human glioblastoma cultured cells

International Journal of Radiation Biology

Volumn 76, Issue 3, 2000, Pages 335-341

  Takahashi, A ^a   Ohnishi, K ^a   Tsuji, K ^b   Matsumoto, H ^a,e   Aoki, H ^a   Wang, X ^a,f   Tamamoto, T ^a   Yukawa, O ^c   Furusawa, Y ^c   Ejima, Y ^d,g   Tachibana, A ^d   Ohnishi, T ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF FUKUI   (Japan)

^f WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^g Hiroshima Prefectural Coll Hlth Sci   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALPHA RADIATION; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TIME; X RAY;

EID: 0034063799     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530000138673     Document Type: Article

References (50)

1. Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Cancer Research, 55, 2387-2393.
2. BALCER-KUBICZEK, E. K., YIN, J., LIN, K., HARRISON, G. H.; ABRAHAM, J. M. and MELTZER, S. J., 1995, p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X-rays or fission neutrons. Radiation Research, 142, 256-262.
3. BIARD, D. S. F., MARTIN, M., RHUN, Y. L., DUTHU, A., LEFAIX, J. L., MAY, E. and MAY, P., 1994, Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epitherial cells during neoplastic development. Cancer Research, 54, 3361-3364.
4. BLAKELY, E. A., CHANG, P. Y., LOMMEL, L., BJORNSTAD, K., DIXON, M., TOBIAS, C. A., KUMAR, K. and BLAKELY, W. F., 1989, Cell-cycle radiation response: role of intracellular factors. Advances in Space Research, 9, 177-186.
5. BLAKELY, E. A., NGO, F. Q. H., CURTIS, S. B. and TOBIAS, C. A., 1984, Heavy-ions radiobiology: cellular studies. Advances in Radiation Biology, 11, 295-389.
6. BRACHMAN, D. G., BECKETT, M., GRAVES, D., HARAT, D., VOKES, E. and WEICHSELBAUM, R. R., 1993, p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research, 53, 3667-3669.
7. BRISTOW, R. G., KANG, A., PEACOCK, J., CHUNG, S., BENCHIMOL, S. and HILI., R. P., 1994, Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene, 9, 1527-1536.
8. BROOKS, A. L., NEWTON, G. J., SHYR, L. J., SEILER, F. A. and SCOTT, B. R., 1990, The combined effects of α-particles and X-rays on cell killing and micronuclei induction in lung epithelial cells. International Journal of Radiation Biology, 58, 799-811.
9. CHEN, G. T. Y., CASTRO, J. R. and QUIVEY, J. M., 1981, Heavy charged particle radiotherapy. Annual Review of Biophysics and Bioengineering, 10, 499-529.
10. DILEONARDO, A., LINKE, S. P., CLARKIN, K. and WAHL, G. M., 1994, DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes and Development, 8, 2540-2551.
11. DULIC, V., KAUFMAN, W., WILSON, S., TISTY, T., LEES, E., HARPER, J., ELLEDGE, S. and REED, S., 1994, p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
12. EL-DEIRY, W. S., TOKINO, T., VELCULESCU, V. E., LEVY, D. B., PARSONS, R., TRENT, J. M., LIN, D., MERGER, W. E., KINZLER, K. W. and VOGELSTEIN, B., 1993, WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
13. FAN, S., SMITH, M. L., RIVET II, D. J., DUBA, D., ZHAN, Q., KOHN, K. W. and FORNACE, Jr. A. J., 1995, Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Research, 55, 1649-1654.
14. GOLDSTEIN, L. S., PHILLIPS, T. L., FU, K. K., ROSS, G. Y. and KANE, L. L., 1981, Biological effects of accelerated heavy-ions. I. Single doses in normal tissue, tumors, and cells in vitro. Radiation Research, 86, 529-541.
15. GOODHEAD, D. T., 1995, Molecular and cell models of biological effects of heavy-ions radiation. Radiation and Environment Biophysics, 34, 67-72.
16. HALL, P. A., MEEK, D. and LANE, D. P., 1996, p53-integrating the complexity. Journal of Pathology, 180, 1-5.
17. HICKMAN, A. W., JARAMILLO, R. J., LECHNER, J. F. and JOHNSON, N. F., 1994, α-particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Research, 54, 5797-5800.
18. KANAI, T., FURUSAWA, Y., FUKUTSU, K., ITSUKAICHI, H., EGCHI-KASAI, K. and OHARA, H., 1997, Irradiation of mixed beam and design of spread-out Bragg peak for Heavy-ion radiotherapy. Radiation Research, 147, 78-85.
19. KANAI, T., KOHNO, T., MINOHARA, S., SUDOU, M., TAKADA, E., SOGA, F., KAWACHI, K. and FUKUMURA, A., 1993, Dosimetry and measured differential W values of air for Heavy ions. Radiation Research, 135, 293-301.
20. KERN, S. E., PIETENPOL, J. A., THIAGALINGAM, S., SEYMOUR, A., KINZLER, K. W. and VOGELSTEIN, B., 1992, Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827-830.
21. LEE, J. and BERNSTEIN, A., 1993, p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 5742-5746.
22. LOU, Y., HURWITZ, J. and MASSAGUE, J., 1995, Cell cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature, 375, 159-161.
23. MATSUMOTO, H., SHIMURA, M., OMATSU, T., OKAICHI, K., MAJIMA, H. and OHNISHI, T., 1994, p53 proteins accumulated by heat stress associated with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Letters, 87, 39-46.
24. MATSUMOTO, H., WANG, X. and OHNISHI, T., 1995, Binding between wild-type p53 and hsp72 accumulated after UV and γ-ray irradiation. Cancer Letters, 92, 127-133.
25. MCILWRATH, A. J., VASEY, P. A., ROSS, G. M. and BROWN, R., 1994, Cell cycle arrest and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Research, 54, 3718-3722.
26. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKI, M., WANG, H., LIN, H., LIEBERMANN, D., HOFFMAN, B. and REED, J., 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
27. NAGASAWA, H. and LITTLE, J. B., 1992, Induction of sister chromatid exchanges by extremely low doses of α-particles. Cancer Research, 52, 6394-6396.
28. NAMBA, H., HARA, T., TUKAZAKI, T., MIGITA, K., ISHIKAWA, N., ITO, K., NAGATAKI, S. and YAMASHITA, S., 1995, Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Research, 55, 2075-2080.
29. O'CONNOR, P. K., JACKMAN, J., BAE, I., MYERS, T. G., FAN, S., MUTOH, M., SCUDIERO, D. A., MONKS, A., SAUSVILLE, E. A., WEINSTEIN, J. N., FRIEND, S., FORNACE, A. J. Jr and KOHN, K. W., 1997, Characterization of the p53 tumor suppressor pathway in cell lines of the national cancer institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Research, 57, 4285-4300.
30. O'CONNOR, P. K., JACKMAN, J., JONDLE, J., BHATIA, K., MAGRATH, I. and KOHN, K. W., 1993, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Research, 53, 4776-4780.
31. OHNISHI, T., WANG, X., OHNISHI, K., MATSUMOTO, H. and TAKAHASHI, A., 1996, p53-dependent induction of WAF1 by heat treatment in human glioblastoma cell lines. Journal of Biological Chemistry, 271, 14510-14513.
32. OKAMOTO, K. and BEACH, D., 1994, Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO Journal, 13, 4816-4822.
33. PARDO, F. S., SU, M., BOREK, C., PREFFER, F., DOMBKOWSKI, D., GERWECK, L. and SCHMIDT, E. V., 1994, Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiation Research, 140, 180-185.
34. PEACOCK, J. W., CHUNG, S., BRISTOW, R. G., HILL., R. P. and BENCHIMOL, S., 1995, The p53-mediated G1 checkpoint is retained in tumorigenic rat embryofibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras. Molecular and Cellular Biology, 15, 1446-1454.
35. RAJU, M. R., EISEN, Y., CARPENTER, S., JARRETT, K. and HARVEY, W. F., 1993, Radiobiology of alpha particles. IV. Cell inactivation by alpha particles of energies 0.4-3.5 MeV. Radiation Research, 133, 289-296.
36. REINKE, V. and LOZANO, G., 1997, The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene, 15, 1527-1534.
37. WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene, 11, 1899-1905.
38. SASAKI, M., 1996, An α-particle irradiation apparatus for biological experiments. Radiation Biology Research Communications, 31, 85-89. [in Japanese]
39. SATO, K., YAMADA, S., OGAWA, H., KAWACHI, K., ARAKI, N., ITANO, A., KANAZAWA, M., KITAGAWA, A., KOHNO, T., KUMADA, M., MURAKAMI, T., MURAMATSU, M., NODA, K., SATO, S., SATO, Y., TAKADA, E., TASHIRO, K., TORIKOSHI, M., YOSHIZAWA, J., ENDO, M., FURUSAWA, Y., KANAI, T., KOYAMA-ITO, H., MATSUFUJI, N., MINOHARA, S., MIYAHARA, N., SOGA, F., SUZUKI, M., TOMURA, H. and HIRANO, Y., 1995, Performance of HIMAC. Nuclear Physics, A588, 229-234.
40. SELVAKUMARAN, M., LIN, H., MIYASHITA, T., WANG, H., KRAJEWSKI, S., REED, J., HOFFMAN, B. and LIEBERMANN, D., 1994, Immediate early up-regulation of bax expression by p53 but not TGF/β1: paradim for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
41. SHEIKH, M. S., LI, X. S., CHEN, J. C., SHAO, Z. M., ORDONEZ, J. V. and FONTANA, J. A., 1994, Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathway. Oncogene, 9, 3407-3415.
42. SHIVJI, M. K., GREY, S. J., STRAUSFIELD, U. P., WOOD, R. D. and BLOW, J. J., 1994, Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Current Biology, 4, 1062-1068.
43. SLICHENMEYER, W. J., NELSON, W. G., SLEBOS, R. J. and KASTAN, M. B., 1993, Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research, 53, 4164-4168.
44. SUGANO, T., NITTA, M., OHMORI, H. and YAMAIZUMI, M., 1995, Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the hea shock response, independently of the cell cycle. Japanese Journal of Cancer Research, 86, 415-418.
45. TSUJH, H., 1977, Clinical evaluation and perspective of charged particle therapy. Nippon Rinsho, 55, 1588-1595.
46. ULLRICH, S., MERCER, E. and APPELLA, E., 1992, Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells. Oncogene, 7, 1635-1643.
47. WADE, H. J., ADAMI, G. R., WEI, N., KEYOMARSI, K. and ELLEDGE, S. J., 1993, The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
48. WANG, X., OHNISHI, K., TAKAHASHI, A. and OHNISHI, T., 1998, Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation. Oncogene, 17, 2819-2825.
49. WAF1 and proliferating cell. Current Biology, 5, 275-282.
50. XIONG, Y., HANNON, G. J., ZHANG, H., CASSO, D., KOBAYASHI, R. and BEACH, D., 1993, p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.